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POUCHITIS is  a  major  long-term  complication  of  the
continent  ileostomy  as  well  as  the  ileoanal  pouch
anastomosis. When diagnosed on the basis of clinical,
endoscopic  and  histologic  features,  this  syndrome
has been demonstrated almost exclusively in patients
with ulcerative colitis. The clinical course, the endo-
scopic  findings  and  the  histologic  abnormalities
resemble those of ulcerative colitis. The association
with extra-intestinal manifestations further supports
the  hypothesis  that  pouchitis  represents  ulcerative
colitis in the small bowel.  All ileal reservoirs show
bacterial  overgrowth,  especially  of  anaerobes.  As  a
response  to  this  altered  intraluminal  environment
chronic inflammation and  incomplete  colonic met-
aplasia occur.  The efficiency of metronidazole does
suggest that bacteriological factors play an important
role in the pathogenesis of pouchitis.
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Introduction
In  the  past,  a  permanent  Brooke  ileostomy  was
inevitable  for  patients  requiring  a  proctocolectomy
for either  ulcerative colitis or familial adenomatous
polyposis. During the past two decades, the continent
ileostomy, devised by Kock, and the ileoanal anasto-
mosis,  introduced  by  Parks  and  Utsunomiya,  have
evolved into attractive alternatives. Both procedures
have the advantage of removing all diseased mucosa
while avoiding a conventional and incontinent ileost-
omy. The construction of an ileal reservoir, however,
frequently  results  in  mucosal  alterations. Although
most  of  these  alterations  remain  subclinical,  some
patients will develop a clinical syndrome known as
pouchitis. Although it has been suggested that faecal
stasis  with  subsequent  alterations  in bacterial  flora
might be important in the pathogenesis of pouchitis,
the exact role of intestinal microflora remains con-
troversial. Therefore it might be worthwile to review
the current concepts with regard to pathogenesis and
aetiology  of  pouchitis  and  to  analyse  the  different
treatment modalities.
History
In  the  1940s  and  early  1950s  it  became  apparent
that mucosal inflammation immediately proximal to
the  ileostomy  was  a  not  uncommon  complication
after colectomy for ulcerative colitis.1 This prestomal
ileitis  resulted  occasionally  in  perforation  of  the
diseased small bowel as described by Crandon et al.
in  1944.2 Initially  this  complication  was  felt  to  be
related to preoperative ‘backwash’ ileitis.1–4 In 1956
Counsell reported successful treatment of prestomal
ileitis by stomal dilatation and lavage with a catheter.
Since then it became widely accepted that prestomal
ileitis was  secondary to  chronic  ileostomy  obstruc-
tion.5 In 1976 Kock reported mucosal inflammation
in  14  out  of  164  patients  in  whom  a  continent
ileostomy was constructed. The inflammatory chan-
ges  in  the  reservoir  occurred  soon  after  pouch
construction  or  as  late  as  several  years  and  were
associated with an increase in ileostomy output and
a  foul-smelling  bloody  effluent.  Other  symptoms
such  as nausea, vomiting and fever were also pres-
ent.  All  patients  had  been  successfully  treated  by
catheter  drainage  and  sulphasalazine.6 Kock  sug-
gested  that  this  mucosal  inflammation  was  due  to
fecal stasis and overgrowth of anaerobic bacteria and
advocated the term pouchitis to describe this non-
specific ileitis. This syndrome, which also occurs in
pelvic reservoirs after ileoanal anastomosis, has been
described  variably  as  stagnant  loop  syndrome7 or
mucosal  enteritis.8,9
Incidence
The reported incidence of pouchitis following restor-
ative proctocolectomy varies considerably from 10%
to 50%  (Table 1). This discrepancy is to a great extent
due  to  the  variability  in  definition,  the  different
numbers  of  patients  investigated  and  the  different
length  of  follow-up.  Furthermore,  in  most  series
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tures have  been infrequently  described. Similar  fig-
ures have been documented in consecutive series of
patients with a continent ileostomy. Hult´ en et al.33
reported that the cumulative probability of develop-
ing a first attack of pouchitis over a 10-year period is
about 35% of patients with a Kock-pouch. Life table
analysis of data derived from a register of all patients
who  have  undergone  ileoanal  anastomosis  at  the
Mayo Clinic revealed a cumulative risk of pouchitis of
31%  for  patients  with  ulcerative  colitis.21 Although
pouchitis occurs both early and late following reser-
voir  construction, most  patients  develop  their  first
episode within 2 years postoperatively.22,28 Approx-
imately  half  of  the  patients  have  only  one  single
episode,  whereas  the  others  present  two  or  more
episodes.22,24 Rauh et al.24 reported a preponderance
of  indeterminate  colitis  in  patients  with  recurrent
episodes of pouchitis. Although  pouchitis has been
reported  to  occur  before  ileostomy  closure,  this
complication  is seen  predominantly after  ileostomy
closure.28 Another  intriguing  observation  is  that
pouchitis appears confined to patients operated on
for ulcerative colitis, whether the pouch is placed in
the pelvis or constructed as a continent ileostomy.34
However,  in  1990  Kmiot  et  al.35 reported  a  fully
documented case of pouchitis in a patient following
ileal reservoir construction for familial adenomatous
polyposis. A similar case has been described in 1991
by Rauh et al.24 Reviewing their patients operated on
for familial adenomatous polyposis, Lohmuller et al.21
found a cumulative risk of pouchitis of 6%. However,
in  this  study  pouchitis  was  defined  as  present  if
patients had abdominal cramping, watery diarrhoea,
urgency,  incontinence,  malaise  and  fever,  without
endoscopic evaluation and histopathologic confirma-
tion. Despite these and other anecdotal reports it is
widely accepted that pouchitis is confined to patients
operated on for ulcerative colitis.
Diagnostic Criteria
Pouchitis  has  been  defined  using  various  criteria.
Some  authors  have  favoured  a  diagnosis  based  on
clinical symptoms, whereas others recommended the
use  of  endoscopic  or  histologic  features.  Because
different diagnostic criteria have been adopted, it is
difficult  to  interpret  the  reported  data  related  to
pouchitis. Taking this into account, it is obvious that
there  is  a  need  for  a  gold  standard  in  diagnosis.
Recently, it has been advocated that an unequivocal
diagnosis  should  be  based  on  a  diagnostic  triad,
consisting  of  the  following  components:  clinical
symptoms,  endoscopic  features  of  acute  inflamma-
tion and histological evidence of a prominent poly-
morphonuclear cell exudate.34
Clinical symptoms
Watery and sometimes bloody diarrhoea is the major
clinical  symptom  of  pouchitis.  The  increased  fre-
quency of stools may be associated with abdominal
discomfort, urgency, incontinence and even dehydra-
tion. Some patients also have fever and malaise. It has
become  apparent  that  pouchitis  has  the  ability  to
evoke arthritis, skin lesions and eye problems, resem-
bling the extra-intestinal manifestations of inflamma-
tory bowel disease. Lohmuller et al.21 showed that
patients with preoperative extra-intestinal manifesta-
tions had significant higher rates of pouchitis than did
patients without these manifestations (39%  vs. 26%).
They also described patients in whom extra-intestinal
manifestations only recurred when pouchitis occurred
and abated when pouchitis was treated.21This relation-
ship is one of the intriguing findings suggesting that
pouchitis  is  likely  associated  with  the  underlying
pathophysiologic  mechanism  involved  in  ulcerative
colitis.
Endoscopic features
As  soon  as  faecal  material  enters  the  pouch,  its
endoscopic  aspect  begins  to  change. The  mucosa
becomes  slightly  swollen  and  somewhat  redder  in
appearance.36 These  mild  inflammatory  changes,
however,  seem  to  be  present  in only  a  few  cases.
DiFebo et al.23 found normal mucosa in 33 out of 41
asymptomatic  patients  with  a  pelvic  reservoir,
whereas endoscopy revealed focal lesions including
oedema, petechiae and single ulcers in eight patients
without clinical symptoms of pouchitis. Endoscopic
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Table  1.  Incidence  of  pouchitis  following  restorative
proctocolectomy
Author Year Pouchitis (% )
Fonkalsrud10 1984 44
Nicholls et al.11 1985 11
Schoetz et al.12 1986 7
Becker and Raymond13 1986 18
O’Connell et al.14 1986 30
Gustavsson et al.15 1987 15
Pemberton et al.16 1987 14
Fleshman et al.17 1988 16
Pescatori et al.18 1988 14
Everett19 1989 27
Oresland et al.20 1989 30
Lohmuller et al.21 1990 29
Wexner et al.22 1990 27
DiFebo et al.23 1990 13
Rauh et al.24 1991 14
Santavirta et al.25 1991 30
De Silva et al.26 1991 21
McMullen et al.27 1991 15
Fozard and Pemberton28 1992 31
Clausen et al.29 1992 18
Gemlo et al.30 1992 31
Luukkonen et al.31 1994 23
Ståhlberg et al.32 1996 51criteria for pouchitis are well known indicators of an
acute non-specific inflammation: granularity, oedema,
erythema,  friability,  petechiae,  hypersecretion  and
multiple  superficial  erosive  defects. Although  these
changes may be focal, they frequently affect all the
mucosa, extending sometimes into the afferent limb
of  the  ileum  above.  In  the  majority  of  cases  the
endoscopic  features  of  pouchitis  mimic  those  of
ulcerative colitis. In  some  patients, however, endo-
scopic aspects resembles pseudomembranous enter-
itis,  whereas  in  other  patients  ulcers  are  observed
similar to those seen in Crohn’s disease.23The degree
of macroscopic inflammation seems to be related to
the  frequency  of  defecation  as  well  as  to  the
histological grade of acute inflammation.37
Histologic criteria
Several studies have shown that ileal pouch mucosa
undergoes morphological changes as soon as faecal
material enters the pouch. In the majority of patients
mucosal biopsy specimens reveal a chronic inflamma-
tory infiltrate in the lamina propria, including lympho-
cytes, plasma cells, eosinophils and histiocytes. Such
an infiltrate, associated with some degree of villous
atrophy and crypt hyperplasia, was found in 87%  of
the reservoirs, studied by Shepherd et al.38 Patients
with  ulcerative  colitis  did  not  show  a  significant
difference in chronic inflammatory score compared
with  those  operated  on  for  familial  adenomatous
polyposis.  The  histopathological  appearance  of
chronic inflammation combined with villous atrophy
resembles  that  of  inactive  ulcerative  colitis.  It  has
been  noted  that  in  patients  with  a  conventional
ileostomy  the  normal  villous  architecture  of  the
prestomal mucosa is preserved, despite the presence
of  chronic  inflammatory  changes.39 This  finding
indicates that flattening of the villi and crypt hyper-
plasia is more likely to be induced after construction
of  an  ileal  reservoir  than  after  the  creation  of  a
conventional  ileostomy.  It  has  been  suggested  that
these morphological changes, which are irrespective
of the original diagnosis, reflect an adaptive response
to the new luminal  environment. The change from
villous  structure  of  small  bowel  to  a  glandular
morphology  of  colon  is sometimes  so pronounced
that  biopsy  specimens  are  indistinguishable  from
normal  colon  on  routine  histologic  examination.
Initially this metaplasia has been defined by means of
the histological changes, such as villous atrophy, crypt
hyperplasia  and  increased numbers  of  Goblet  cells
and lysozyme containing Paneth’s cells. Recent his-
tochemical studies, however, have shown that in 50%
of the cases colonic metaplasia is also characterized
by  a  change  from  small  intestinal  sialomucin  to
colorectal sulphamucin.38,40 Despite this metaplasia,
pouch  mucosa  retains  small  bowel  characteristics,
supported by the finding of sucrase-isomaltase activ-
ity in pouch specimens.40 Furthermore, it has been
shown  that  no  alteration  occurs  in  endocrine  cell
population.
41 In pouchitis the mucosa shows a dense
acute inflammatory cell infiltrate, consisting of poly-
morphic  granulocytes,  associated  with  crypt  abs-
cesses and ulcerations. Frequently the villous atrophy
becomes  more  extensive  and  subtotal.  The  histo-
logical  grade  of  acute  inflammation  is  significantly
related  to  the  clinical  symptoms.37 The  histologic
findings in pouchitis are very similar to those seen in
acute ulcerative colitis.
Pathogenesis
Bacterial overgrowth
Faecal  stasis  with  bacterial  overgrowth  has  been
considered a major contributing factor in the patho-
genesis of pouchitis. Ileal reservoirs are colonized with
large numbers of bacteria that outnumber the flora of
the normal terminal ileum.14,25,39,42–45 In ileal reser-
voirs, without signs of pouchitis, the microflora closely
resembles the flora of the large bowel. This is mainly
due  to  the  large  numbers  of  anaerobes  (especially
Bacteroides and Bifidobacteria), resulting in a greater
ratio of anaerobes to aerobes.25,42–46 In only one study
bacterial counts in ileal reservoirs were identical with
normal  stool  values.47 Other  studies,  however,
revealed  that  the  microflora  holds  an  intermediate
position  between  ileostomy  effluent  and  normal
faeces.42,46,48 It has been suggested that incomplete
emptying of the pouch, which is associated with stasis
of ileal contents, would result in an increase in the
number of anaerobic bacteria. Comparing S and W
reservoirs Sagar et al.49 found a reduced efficiency of
evacuation  in  S  reservoirs.  The  effluent  of  these
reservoirs  had  a  significantly  greater  number  of
Bacteroides.  In  another  study,  however,  bacterial
overgrowth with an increased number of anaerobes
was found in all pouches, irrespective of the efficiency
of evacuation.14 In both studies no correlation was
found between the efficiency of evacuation and the
grade of mucosal inflammation. Similar findings have
been reported by others.39,50Therefore, it seems likely
that exposure to the faecal stream, rather than  the
amount  of  stasis,  is  the ‘threshold’  factor  for  the
development  of  mucosal  changes  found  in  ileal
reservoirs. The increased numbers of bacteria appear
responsible for the increased crypt cell production
rate and villous atrophy observed in the pouch mucosa
soon after the construction of the reservoir.43 Nasmyth
et al.45 found a significant correlation between the
number of isolated Bacteroides and the grade of villous
atrophy. The greater the number of Bacteroides the
more severe was the villous atrophy. Conversely, the
higher the concentration of feacal butyrate the less
severe was the villous atrophy.45 Both findings appear
to be contradictory, because volatile fatty acids, such as
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fermentation of intraluminal carbohydrate. However,
very few species of Bacteroides produce butyrate and
it might be speculated that in vivo butyrate suppresses
the growth of Bacteroides. It is yet not clear whether
the grade of chronic inflammation correlates with the
number of bacteria isolated. In two studies the score
for  chronic  inflammation  was  correlated  to  the
number  of  anaerobes.25,51 However,  other  inves-
tigators  could  not  demonstrate  such  a  consistent
correlation  between  bacterial  counts  and  chronic
inflammation.45,52 The  prompt  response  in  some
patients  with  clinical  pouchitis  to  metronidazole
suggests the possibility that overgrowth of anaerobes
may be important. However, there is a great deal of
controversy concerning the correlation between anae-
robes and pouchitis. Several studies failed to show a
quantitative  or  qualitative  difference  between  the
microbial  findings  in  patients  with  and  without
pouchitis.14,39,44,53 A recent study, conducted at our
own institution, also failed to show significant differ-
ences in the total numbers of bacteria when pouch
effluent  from controls and patients was  compared.
However,  patients  with  pouchitis  had  a  different
composition of the flora. Several anaerobes, such as
bifidobacteria and anaerobic lactobacilli, disappeared
in favour of aerobes. This was reflected in the ratio
anaerobes  to  aerobes:  patients  without  pouchitis
harboured more than hundred times more anaerobes
than  aerobes. Patients with pouchitis had only two
times more anaerobes.54These observations have been
confirmed  by  Onderdonk  et  al.55 who  cultered
significantly more aerobes from tissue biopsy samples
from  patients  with  pouchitis  than  from  control
patients.  Our  study  also  revealed  that  the  flora  of
patients with pouchitis is rather unstable. We cultured
several species that were not found in controls, such as
fungi,  Bacillus  species  and  Candida  species.  Fur-
thermore, Clostridium perfringens was detected in
nearly  every  pouchitis,  sometimes  in  very  high
numbers.54 A selective increase of Clostridium per-
fringens has  also  been  documented by Brandi  and
coworkers.56 The exact role of C perfringens in the
pathogenesis of pouchitis is still unknown.
Mucosal ischaemia
It  has  been  suggested that  transient  ischaemia  and
subsequent reperfusion may be an aetiological factor
in the pathogenesis of pouchitis. It is well known that
the  vessels  supplying  the  terminal  ileum  are  often
under  tension  when  the  ileoanal  anastomosis  is
completed. Frequently, these vessels must be divided
to provide adequate length for performing the anasto-
mosis. Using fluorescein flowmetry and laser Doppler
flowmetry it has been shown that mucosal bloodflow
in pelvic reservoirs is significantly reduced compared
with the mucosal bloodflow in conventional ileosto-
mies.57,58 Sakaguchi  et  al. have  reported  that  in
patients with pouchitis the mucosal bloodflow was
less than in healthy reservoirs.58 In ischaemic tissues,
xanthine  dehydrogenase  is  converted  to  xanthine
oxidase. During reperfusion this enzyme catalyses a
reaction resulting in the liberation of oxygen-derived
free radicals, which can be prevented by the admin-
istration of allopurinol. To investigate the role of this
xanthine oxydase inhibitor Levin et al. conducted a
study  in  patients  with  pouchitis.  They  found  a
benefical effect of allopurinol in 50% of the patients,
either with acute or chronic pouchitis.53 The results
of this preliminary study are consistent with a role for
mucosal ischaemia in the aetiology of pouchitis.
Short-chain fatty acids
Short-chain  fatty  acids  (SCFAs)  are  the  product  of
anaerobic  bacterial  fermentation  of  dietary  fibres.
They are the preferred energy substrates for colono-
cytes and have a trophic effect  on the large bowel
mucosa. It has been suggested that these SCFAs are
also  an  important  energy  source  for  the  pouch
epithelium, which  can undergo colonic metaplasia.
Moreover, it has been shown that SCFAs are able to
suppress  enteropathic  bacteria  that  produce  toxic
metabolites,  which  in  turn  may  cause  mucosal
inflammation.59 In view of the increased numbers of
anaerobes, increased production of SCFAs might be
expected in ileal reservoirs. Nasmyth et al.45 demon-
strated  that  the  concentration  of  SCFAs  in  the
effluent  from  normal  pouches  exceeds  that  from
ileostomies. However, no significant difference was
found  between  the  SCFA-concentration  in  faecal
specimens from pouch patients and normal subjects.
The  only  difference  between  the  effluent  from
pouches and that from normal subjects was a higher
concentration  of  acetate  in  the  effluent  from  the
pouches.45 In contrast with this finding, Ambroze et
al.60 reported  lower  concentrations  of  SCFAs  in
pouch  effluent  compared  with  normal  stool.  In  a
preliminary  report  Wischmeyer  et  al.61 described
reduced  concentrations  of  SCFAs  in  patients  with
pouchitis compared with patients without pouchitis.
Recently, this finding was confirmed by others.29 It
seems likely that the lower concentrations of SCFAs
are  due  to  the  reduced  numbers  of  anaerobes.
Whether  the  reduced  concentrations  of  SCFAs  are
the result rather than the cause of pouchitis has not
been determined. The effect of local application of
SCFAs on pouchitis has been studied by DeSilva et
al.62 Two  patients  with  severe  pouchitis  that  was
resistant  to  treatment  with  metronidazole,  5-amino
salicylic acid and corticosteroids, received 60ml of a
SCFA  solution  twice  daily.  Treatment  was  discon-
tinued when deterioration was seen in both patients
after  14  and  28  days  respectively.  Based  on  these
results it seems unlikely that low concentrations of
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pouchitis.62
Bile acids
It has been suggested that the bacterial overgrowth in
ileal reservoirs might result in an increased bacterial
deconjugation of bile acids. It is well known that the
bacteria in the terminal ileum are able to hydrolyse
the conjugated bile acids and to dehydroxylate the
bile acids to secondary bile acids. It has been shown
that desoxycholic acid (a secondary bile acid) causes
a progressive increase in water and salt permeability
followed  by  cell  death  in  the  rat  colon.63 Could
secondary and deconjugated bile acids cause pouchi-
tis?  In  one  study,  comparing  patients  with  and
without  pouchitis, the concentrations of both total
conjugated bile acids and tauroconjugated bile acids
were found to be lower in pouchitis patients, which
suggests  an  increased  bacterial  deconjugation  in
pouchitis.59 In another study it has been shown that
ileal pouch dialysate is cytotoxic to intestinal epithe-
lial cell lines. This effect was inhibited by cholestyr-
amine, which suggests that  a bile  acid may be the
cytotoxic factor.64
Recurrence of ulcerative colitis
One of the most intriguing aspects of pouchitis is the
observation  that  this  complication  occurs  almost
exclusively  in patients who undergo  colectomy  for
ulcerative colitis. Based on this finding, it has been
suggested that ulcerative colitis and pouchitis share
the  same  aetiology.  The  observation  that  some
patients  with  inflamed reservoirs  experience extra-
intestinal manifestations resembling those occurring
in ulcerative colitis supports this theory. Many studies
have  confirmed  that  the  pouch  mucosa  undergoes
morphological  changes  and acquires  characteristics
resembling  those  of  colonic  mucosa.  This  colonic
metaplasia  seems  to  be  a  nonspecific  adaptive
response  to  the  new  luminal  environment  that
favours the development of an ulcerative colitis-like
condition.65 Exposure to the faecal stream is probably
the initiating event that allows the onset of inflamma-
tory changes.66 It has been shown that colonic mucin
glycoproteins are altered in patients with ulcerative
colitis.67 It  could  be  possible  that  the  aberrated
glycoproteins  are  more  susceptible  for  bacterial
enzymatic degradation, making the mucus barrier less
resistant  to  toxins. The  findings  that  pouch  mucin
resembles  colonic mucin  is  therefore  an  important
one.  In  recent  years  increasing  numbers  of  data
further support the hypothesis that pouchitis repre-
sents recurrent ulcerative colitis. In a study aimed to
characterize  the  mucosal  cellular  infiltrate  in  ileal
reservoirs, de  Silva et al.68 found  increased RDF9+
macrophage subpopulations in pouchitis. This finding
suggests  that  the  effector  mechanisms  triggering
pouchitis are similar to those in ulcerative colitis. In
another study the production of eicosanoids, arachi-
donic  acid  and  interleukin-1b was  found  to  be
elevated  in  inflamed  reservoirs,  indicating  that  in
pouchitis  the  same  inflammatory  mediators  are
involved  as  in  ulcerative  colitis.69 An  increased
expression  of  cell  adhesion  molecules  (E  selection
and  intercellular  adhesion  molecule-1)  has  been
demonstrated in pouchitis, similar to that reported in
ulcerative colitis.70 Like ulcerative colitis, pouchitis is
associated with an increased production of platelet-
activating factor, indicating that both disorders share
the  same aetiology.66 Merrett  et al. reported fewer
episodes  of  pouchitis  in  smokers  than  in  non-
smokers.71 Such  a  ‘protective’  influence  has  pre-
viously  been  described  in  smokers  with  ulcerative
colitis. All these data suggest that ulcerative colitis can
occur in the small intestine on the condition that the
luminal environment acquires certain colonic charac-
teristics. Bacterial overgrowth is probably the initiat-
ing event in this process of colonic metaplasia.
Treatment
Numerous anecdotal reports  have shown  that  pou-
chitis  is  responsive  to  antibacterial  therapy  with
metronidazole. According to Fozard and Pemberton
the  majority  of  patients respond rapidly to  a  short
course of treatment.28 In their series only 3%  of the
patients  were  refractory  to  this  therapy  or  had
severe  side  effects.  O’Connell  reported that  all  his
patients  with  pouchitis  obtained  prompt  relief  of
symptoms.14 Comparing pouchitis with and without
mucosal  ulceration,  Zuccaro  et  al.72 observed  a
therapeutic effect of metronidazole in 20%  and 78%
respectively. This finding indicates that antibacterial
treatment  is probably less effective than  previously
reported.  Based  on  the  observation  that  some
patients  do  not  respond  to  metronidazole,  it  has
been suggested that there are at least two forms of
pouchitis:  a  bacteriological  one  that  responds  to
metronidazole  and one  that  requires other  medica-
tion. The effectiveness of metronidazole can only be
assessed in a controlled trial, which is also necessary
for  proper  recommendations  regarding  dosage
schedules  and  duration  of  treatment. The  observa-
tion that clinical symptoms are often resolved with
a short course of metronidazole supports a bacterio-
logical basis of pouchitis. However, the actual mech-
anism  of  action of  metronidazole  is still  uncertain.
Levin  et  al. suggested  that  metronidazole  affects
pouchitis not  by an antibacterial action, but  rather
by its  capacity  to  remove  oxygen  radicals.53 Other
workers raised the possibility that metronidazole has
a  therapeutic  effect  because  of  its  immunosup-
pressive  activity.73 This  is  of  interest  as  metronida-
zole does not appear to have a role in the treatment
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nism of action of metronidazole can only be eluci-
dated in a study comparing pouch microflora before
and after treatment with metronidazole, whether the
therapy is successful or not. Recent studies suggest
that  pouchitis  is  a  chronic  relapsing  complication
with reported recurrence rates varying between 50%
and  80%.21,23,31,75 It  appears  that  an  increasing
number  of  patients  will  require  intermittent  or
maintenance therapy. The question is whether met-
ronidazole  is  suitable  for  that  purpose  or  not,
particularly  in the light  of the potential for periph-
eral neuropathy and other side effects. Patients who
are  refractory  to  treatment  with  metronidazole
might obtain relief of symptoms after the administra-
tion of enemas containing salicylic acid derivates.76
Even the use of steroids has been advocated in the
treatment  of  persistent  pouchitis.  However,  con-
tinuous administration of steroids with the intention
of saving a sick pouch is questionable. Despite their
suggested  role  in  the  pathogenesis  of  pouchitis,
short-chain  fatty  acids appear to be of no value in
the  treatment  of  pouchitis.62 Recently  it  has  been
shown  that  oxygen-derived  as  well  as  leukocyte-
derived free radicals are involved in the pathogenesis
of ulcerative colitis. Levin demonstrated that allopur-
inol,  a  scavenger  directed  against  oxygen-derived
free  radicals,  induced  a  remission  in  50%   of  the
patients.53 The  value  of  other  scavengers,  directed
against  leukocyte-derived  free  radicals,  such  as
superoxide dismutase, is still unknown.
There is growing evidence that the pouch flora is
very susceptible to influences from outside, such as
dietary variation, stress and bacterial contamination.
This  instability  may  lead  to  microbial  imbalance,
which  might  be a major contributing  factor  in the
pathogenesis of pouchitis.54 Based on this assumption
it might be worthwhile to bring about a stable pouch
flora. This  might  be  realized  by  oral  ingestion  of
lactobacilli, which has been proved to be successful
in the treatment of intestinal infections and antibiotic
associated diarrhoea.54
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Summary
It might be possible that bacterial enzymes, such as
glycosidases,  degrade  the  protecting  mucus,  which
may  become  more  permeable  to  toxic  bacterial
metabolites  and  host-derived  proteolytic  enzymes,
affecting  the  integrity  of  the  mucosa.  As  a  result
bacterial antigens may cross the mucosal barrier. This
translocation of bacterial antigens probably triggers a
cascade of inflammatory events. Only in patients with
ulcerative  colitis  these  inflammatory  events  finally
result  in  clinical  pouchitis.  Ulcerative  colitis  is  a
condition with the potential of neoplastic change in
the large intestine. If pouchitis represents recurrent
ulcerative colitis, then the pouch epithelium might be
prone  to  malignant  transformation.  Although  the
colonic  metaplasia  is  not  complete,  the  reservoir
mucosa  shows  hyperproliferation  both  in  patients
with pouchitis and in those without this syndrome.65
Recently L¨ ofberg et al.77 reported dysplasia and DNA
aneuploidy  in  the  pelvic  pouch  of  a  patient  with
ulcerative colitis. Stern et al.78 described the develop-
ment of a carcinoma in an ileal reservoir of a colitis
patient.  Based  on  these  findings  long-term  endo-
scopic surveillance of the reservoir mucosa has been
recommended.
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